Skip to main content

Acetylcysteine News

FDA Medwatch Alert: Cetylev (acetylcysteine) Effervescent Tablets for Oral Solution: Recall - Inadequate Seal of Blister Pack

ISSUE: Arbor  Pharmaceuticals, LLC announced a voluntary recall of three (3) lots of Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg, due to an inadequate seal of the blister ...

Arbor Pharmaceuticals Announces FDA Approval of Cetylev

Atlanta, GA, February 9, 2016 – Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for Cetylev (acetylcysteine...

FDA Medwatch Alert: Acetylcysteine Solution 10 Percent: Recall - Glass Particles in Product

ISSUE: Ben Venue Laboratories notified health professionals and their medical care organizations of a nationwide product recall of Acetylcysteine Solution 10%, manufactured for Roxane Laboratories,...

FDA Medwatch Alert: Acetylcysteine Solution, USP (Roxane Laboratories, Inc.): Recall - Visible Glass Particle

ISSUE: Bedford Laboratories issued an update to the voluntary recall, initiated December 20, 2011 of one lot of Acetylcysteine Solution (Roxane Laboratories) due to the discovery of a single visible...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Dietary Supplementation

Acetylcysteine patient information at Drugs.com